The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 188 | 13,180 | SH | DFND | 1,2 | 13,180 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 818 | 35,035 | SH | DFND | 1,2 | 35,035 | 0 | 0 | |
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 902 | 41,950 | SH | DFND | 1,2 | 41,950 | 0 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 94 | 27,925 | SH | DFND | 1,2 | 27,925 | 0 | 0 | |
AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 207 | 19,150 | SH | DFND | 1,2 | 19,150 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 396 | 1,130 | SH | DFND | 1,2 | 1,130 | 0 | 0 | |
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 1,695 | 12,600 | SH | DFND | 1,2 | 12,600 | 0 | 0 | |
ATYR PHARMA INC | COM NEW | 002120202 | 176 | 23,500 | SH | DFND | 1,2 | 23,500 | 0 | 0 | |
BEAM THERAPEUTICS INC | COM | 07373V105 | 4,375 | 54,903 | SH | DFND | 1,2 | 54,903 | 0 | 0 | |
BEIGENE LTD | SPONSORED ADR | 07725L102 | 3,036 | 11,205 | SH | DFND | 1,2 | 11,205 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 215 | 15,545 | SH | DFND | 1,2 | 15,545 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 659 | 7,460 | SH | DFND | 1,2 | 7,460 | 0 | 0 | |
BLUEBIRD BIO INC | COM | 09609G100 | 783 | 78,350 | SH | DFND | 1,2 | 78,350 | 0 | 0 | |
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 5,718 | 1,166,952 | SH | DFND | 1,2 | 1,166,952 | 0 | 0 | |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 250 | 22,200 | SH | DFND | 1,2 | 22,200 | 0 | 0 | |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 193 | 11,445 | SH | DFND | 1,2 | 11,445 | 0 | 0 | |
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 594 | 370,950 | SH | DFND | 1,2 | 370,950 | 0 | 0 | |
DICE THERAPEUTICS INC | COM | 23345J104 | 499 | 19,700 | SH | DFND | 1,2 | 19,700 | 0 | 0 | |
DYNE THERAPEUTICS INC | COM | 26818M108 | 138 | 11,629 | SH | DFND | 1,2 | 11,629 | 0 | 0 | |
EARGO INC | COM | 270087109 | 14,722 | 2,886,724 | SH | DFND | 1,2 | 2,886,724 | 0 | 0 | |
EXACT SCIENCES CORP | COM | 30063P105 | 1,359 | 17,464 | SH | DFND | 1,2 | 17,464 | 0 | 0 | |
EXELIXIS INC | COM | 30161Q104 | 1,174 | 64,200 | SH | DFND | 1,2 | 64,200 | 0 | 0 | |
EXSCIENTIA PLC | ADS | 30223G102 | 15,219 | 770,200 | SH | DFND | 1,2 | 770,200 | 0 | 0 | |
GALERA THERAPEUTICS INC | COM | 36338D108 | 2,815 | 613,223 | SH | DFND | 1,2 | 613,223 | 0 | 0 | |
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 32,778 | 768,708 | SH | DFND | 1,2 | 768,708 | 0 | 0 | |
ILLUMINA INC | COM | 452327109 | 49,323 | 129,647 | SH | DFND | 1,2 | 129,647 | 0 | 0 | |
INCYTE CORP | COM | 45337C102 | 2,533 | 34,510 | SH | DFND | 1,2 | 34,510 | 0 | 0 | |
INVITAE CORP | COM | 46185L103 | 2,411 | 157,862 | SH | DFND | 1,2 | 157,862 | 0 | 0 | |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,041 | 78,720 | SH | DFND | 1,2 | 78,720 | 0 | 0 | |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 30,760 | 234,811 | SH | DFND | 1,2 | 234,811 | 0 | 0 | |
KODIAK SCIENCES INC | COM | 50015M109 | 1,139 | 13,440 | SH | DFND | 1,2 | 13,440 | 0 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 163 | 11,650 | SH | DFND | 1,2 | 11,650 | 0 | 0 | |
KYMERA THERAPEUTICS INC | COM | 501575104 | 315 | 4,960 | SH | DFND | 1,2 | 4,960 | 0 | 0 | |
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 435 | 9,340 | SH | DFND | 1,2 | 9,340 | 0 | 0 | |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 266 | 1,810 | SH | DFND | 1,2 | 1,810 | 0 | 0 | |
NEW FRONTIER HEALTH CORP | *W EXP 11/30/202 | G6461G114 | 4,266 | 1,580,000 | SH | DFND | 1,2 | 1,580,000 | 0 | 0 | |
NEW FRONTIER HEALTH CORP | ORD SHS | G6461G106 | 95,691 | 8,350,000 | SH | DFND | 1,2 | 8,350,000 | 0 | 0 | |
OTONOMY INC | COM | 68906L105 | 1,770 | 851,000 | SH | DFND | 1,2 | 851,000 | 0 | 0 | |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 3,514 | 171,760 | SH | DFND | 1,2 | 171,760 | 0 | 0 | |
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 253 | 20,350 | SH | DFND | 1,2 | 20,350 | 0 | 0 | |
RANI THERAPEUTICS HLDGS INC | COM CL A | 753018100 | 8,070 | 493,584 | SH | DFND | 1,2 | 493,584 | 0 | 0 | |
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 218 | 8,265 | SH | DFND | 1,2 | 8,265 | 0 | 0 | |
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 550 | 56,768 | SH | DFND | 1,2 | 56,768 | 0 | 0 | |
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 643 | 142,900 | SH | DFND | 1,2 | 142,900 | 0 | 0 | |
SEAGEN INC | COM | 81181C104 | 7,010 | 45,340 | SH | DFND | 1,2 | 45,340 | 0 | 0 | |
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 1,152 | 52,979 | SH | DFND | 1,2 | 52,979 | 0 | 0 | |
SOMALOGIC INC | CLASS A COM | 83444K105 | 19,748 | 1,696,558 | SH | DFND | 1,2 | 1,696,558 | 0 | 0 | |
SURROZEN INC | COM | 86889P109 | 419 | 65,070 | SH | DFND | 1,2 | 65,070 | 0 | 0 | |
SYNLOGIC INC | COM | 87166L100 | 166 | 68,634 | SH | DFND | 1,2 | 68,634 | 0 | 0 | |
TANGO THERAPEUTICS INC | COM | 87583X109 | 279 | 25,500 | SH | DFND | 1,2 | 25,500 | 0 | 0 | |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,505 | 48,500 | SH | DFND | 1,2 | 48,500 | 0 | 0 | |
TSCAN THERAPEUTICS INC | COM | 89854M101 | 219 | 48,600 | SH | DFND | 1,2 | 48,600 | 0 | 0 | |
VINCERX PHARMA INC | COM NEW | 92731L106 | 113 | 11,050 | SH | DFND | 1,2 | 11,050 | 0 | 0 | |
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 8,816 | 210,563 | SH | DFND | 1,2 | 210,563 | 0 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,182 | 197,880 | SH | DFND | 1,2 | 197,880 | 0 | 0 |